John Kemp

799 total citations
23 papers, 652 citations indexed

About

John Kemp is a scholar working on Psychiatry and Mental health, Pulmonary and Respiratory Medicine and Pharmacology. According to data from OpenAlex, John Kemp has authored 23 papers receiving a total of 652 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Psychiatry and Mental health, 4 papers in Pulmonary and Respiratory Medicine and 4 papers in Pharmacology. Recurrent topics in John Kemp's work include Migraine and Headache Studies (6 papers), Estrogen and related hormone effects (4 papers) and Neurological Complications and Syndromes (3 papers). John Kemp is often cited by papers focused on Migraine and Headache Studies (6 papers), Estrogen and related hormone effects (4 papers) and Neurological Complications and Syndromes (3 papers). John Kemp collaborates with scholars based in United Kingdom, Switzerland and United States. John Kemp's co-authors include Hugh K. Adam, John Patterson, Elaine Douglas, Aaron Dane, Alan E. Wakeling, Roger Slater, Ruth Dixon, KF Ilett, J. Booth and Jane Kendrew and has published in prestigious journals such as Biochemical Pharmacology, Critical Care and Molecular Cancer Therapeutics.

In The Last Decade

John Kemp

23 papers receiving 606 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John Kemp United Kingdom 14 208 189 113 109 96 23 652
B Kattman United States 9 179 0.9× 82 0.4× 126 1.1× 207 1.9× 31 0.3× 25 676
Gordon Loewen United States 13 115 0.6× 140 0.7× 83 0.7× 381 3.5× 49 0.5× 38 861
Megan Kane United States 11 98 0.5× 85 0.4× 114 1.0× 259 2.4× 41 0.4× 28 660
S. K. Paulson United States 11 194 0.9× 113 0.6× 76 0.7× 144 1.3× 52 0.5× 18 752
Evrim Gurpinar United States 8 77 0.4× 228 1.2× 59 0.5× 309 2.8× 71 0.7× 11 952
Chiyo K. Imamura Japan 14 235 1.1× 326 1.7× 255 2.3× 212 1.9× 113 1.2× 54 795
Orazia M. Granata Italy 19 413 2.0× 164 0.9× 91 0.8× 234 2.1× 76 0.8× 40 962
Jai N. Patel United States 20 99 0.5× 331 1.8× 258 2.3× 268 2.5× 117 1.2× 95 1.0k
Randall Harris United States 8 291 1.4× 314 1.7× 19 0.2× 109 1.0× 86 0.9× 9 769
Pritha Bhadra United States 7 153 0.7× 256 1.4× 49 0.4× 140 1.3× 139 1.4× 9 1.1k

Countries citing papers authored by John Kemp

Since Specialization
Citations

This map shows the geographic impact of John Kemp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Kemp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Kemp more than expected).

Fields of papers citing papers by John Kemp

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Kemp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Kemp. The network helps show where John Kemp may publish in the future.

Co-authorship network of co-authors of John Kemp

This figure shows the co-authorship network connecting the top 25 collaborators of John Kemp. A scholar is included among the top collaborators of John Kemp based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Kemp. John Kemp is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yates, James, et al.. (2012). Population pharmacokinetic/pharmacodynamic modelling of the anti-TNF-α polyclonal fragment antibody AZD9773 in patients with severe sepsis. Journal of Pharmacokinetics and Pharmacodynamics. 39(6). 591–599. 3 indexed citations
2.
Kemp, John, et al.. (2011). Disposition and metabolism of the specific endothelin A receptor antagonist zibotentan (ZD4054) in healthy volunteers. Xenobiotica. 42(4). 363–371. 6 indexed citations
3.
Tomkinson, Helen, John Kemp, Stuart Oliver, et al.. (2011). Pharmacokinetics and tolerability of zibotentan (ZD4054) in subjects with hepatic or renal impairment: two open-label comparative studies. PubMed. 11(1). 3–3. 27 indexed citations
4.
5.
Newham, Peter, Shampa Das, John Kemp, et al.. (2011). Preclinical pharmacodynamics and safety profiling of AZD9773: a novel anti-TNFα polyclonal immune ovine Fab similar to D-CytoFab. Critical Care. 15(S1). 2 indexed citations
6.
7.
8.
McKillop, David, E. A. Partridge, John Kemp, et al.. (2005). Tumor penetration of gefitinib (Iressa), an epidermal growth factor receptor tyrosine kinase inhibitor. Molecular Cancer Therapeutics. 4(4). 641–649. 109 indexed citations
9.
Yates, R. A., Jens Christian Hedemann Sørensen, Mats Bergström, et al.. (2005). Distribution of Intranasal 11C-Zolmitriptan assessed by Positron Emission Tomography. Cephalalgia. 25(12). 1103–1109. 25 indexed citations
10.
Martin, Paul, John Kemp, Aaron Dane, Mike J. Warwick, & Dennis W. Schneck. (2002). No Effect of Rosuvastatin on the Pharmacokinetics of Digoxin in Healthy Volunteers. The Journal of Clinical Pharmacology. 42(12). 1352–1357. 42 indexed citations
11.
Yates, R. A., et al.. (2002). The pharmacokinetics of the antimigraine compound zolmitriptan in Japanese and Caucasian subjects. European Journal of Clinical Pharmacology. 58(4). 247–252. 18 indexed citations
12.
Yates, Roger, et al.. (2002). Pharmacokinetics, Dose Proportionality, and Tolerability of Single and Repeat Doses of a Nasal Spray Formulation of Zolmitriptan in Healthy Volunteers. The Journal of Clinical Pharmacology. 42(11). 1244–1250. 29 indexed citations
13.
Dixon, Ruth, et al.. (1999). A Comparison of the Pharmacokinetics and Tolerability of the Novel Antimigraine Compound Zolmitriptan in Adolescents and Adults. Journal of Child and Adolescent Psychopharmacology. 9(1). 35–42. 18 indexed citations
14.
Dixon, Ruth, Stephanie French, John Kemp, et al.. (1998). Effect of Hepatic Impairment on the Pharmacokinetics of Zolmitriptan. The Journal of Clinical Pharmacology. 38(8). 694–701. 8 indexed citations
15.
Dixon, Ruth, Stephanie French, John Kemp, Marty T. Sellers, & R. A. Yates. (1998). The Metabolism of Zolmitriptan. Clinical Drug Investigation. 15(6). 515–522. 13 indexed citations
16.
Price, David E., et al.. (1989). The Effect of Aldose Reductase Inhibition on Erythrocyte Polyols and Galactitol Accumulation in Diabetic Patients. Diabetic Medicine. 6(9). 804–808. 7 indexed citations
17.
Kemp, John, et al.. (1985). Excretion of doxepin and N‐desmethyldoxepin in human milk.. British Journal of Clinical Pharmacology. 20(5). 497–499. 54 indexed citations
18.
Wilkinson, P M, et al.. (1982). Tamoxifen (Nolvadex) therapy ? Radionale for loading dose followed by maintenance dose for patients with metastatic breast cancer. Cancer Chemotherapy and Pharmacology. 10(1). 33–5. 12 indexed citations
19.
Adam, Hugh K., John Patterson, & John Kemp. (1981). Studies on the metabolism and pharmacokinetics of tamoxifen in normal volunteers.. PubMed. 64(6-7). 761–4. 58 indexed citations
20.
Patterson, John, et al.. (1980). Serum concentrations of tamoxifen and major metabolite during long-term nolvadex therapy, correlated with clinical response.. PubMed. Suppl 1. 89–92. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by B Kattman Breakdown of academic impact, for papers by Gordon Loewen Breakdown of academic impact, for papers by Megan Kane Breakdown of academic impact, for papers by S. K. Paulson Breakdown of academic impact, for papers by Evrim Gurpinar Breakdown of academic impact, for papers by Chiyo K. Imamura Breakdown of academic impact, for papers by Orazia M. Granata Breakdown of academic impact, for papers by Jai N. Patel Breakdown of academic impact, for papers by Randall Harris Breakdown of academic impact, for papers by Pritha Bhadra
Rankless by CCL
2026